レーベル遺伝性視神経症（LHON）は、遺伝性の視力低下症です。通常、10代から20代で発症しますが、まれに幼児期や成人期以降に発症することもあります。男性は女性よりはるかに多く罹患します。症状としては、目の痛みや不快感、しびれや痛み、視界の混濁などがあります。加齢、タバコの煙、アルコール、抗癌剤、ストレス関連化学物質、一部の抗生物質、シアノゲンなどが発症の素因とされています。
目次
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Overview
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Companies Involved in Therapeutics Development
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Drug Profiles
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Dormant Projects
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy), 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline by Astellas Pharma Inc, 2022
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline by Biovista Inc, 2022
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline by Evvia Therapeutics Inc, 2022
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline by GenSight Biologics SA, 2022
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline by Imbria Pharmaceuticals Inc, 2022
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline by Ixchel Pharma LLC, 2022
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline by Metro International Biotech LLC, 2022
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline by Mitotech SA, 2022
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline by Neurophth Therapeutics Inc, 2022
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline by Neuroptika Inc, 2022
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline by PYC Therapeutics Ltd, 2022
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline by Stealth BioTherapeutics Corp, 2022
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) - Dormant Projects, 2022
List of Figures
Number of Products under Development for Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy), 2022
Number of Products under Development by Companies, 2022
Number of Products by Targets, 2022
Number of Products by Stage and Targets, 2022
Number of Products by Mechanism of Actions, 2022
Number of Products by Stage and Mechanism of Actions, 2022
Number of Products by Routes of Administration, 2022
Number of Products by Stage and Routes of Administration, 2022
Number of Products by Molecule Types, 2022
Number of Products by Stage and Molecule Types, 2022
